Literature DB >> 9065447

Molecular and functional characterization of the urokinase receptor on human mast cells.

C Sillaber1, M Baghestanian, R Hofbauer, I Virgolini, H C Bankl, W Füreder, H Agis, M Willheim, M Leimer, O Scheiner, B R Binder, H P Kiener, D Bevec, G Fritsch, O Majdic, H G Kress, H Gadner, K Lechner, P Valent.   

Abstract

The urokinase receptor system is involved in several biological processes including extracellular proteolysis, cell invasion, and chemotaxis. Mast cells are multifunctional perivascular cells that play an important role in the regulation of microenvironmental events. We report that primary human mast cells and the human mast cell line HMC-1 express the receptor for urokinase. As assessed by Northern blotting and reverse transcription polymerase chain reaction technique, purified human lung mast cells and HMC-1 cells expressed urokinase receptor mRNA in a constitutive manner. Using a toluidine blue/immunofluorescence double staining technique and monoclonal antibodies, surface expression of urokinase receptor was demonstrable in lung, skin, uterus, heart, and tonsil mast cells, whereas the low density lipoprotein receptor-related protein was not detectable. Binding of monoclonal antibody VIM5 (recognizing the urokinase binding domain of urokinase receptor) to HMC-1 could be blocked by high molecular weight but not low molecular weight urokinase. Binding analyses performed with 123I-urokinase revealed expression of 271,000 +/- 55,000 high affinity urokinase binding sites per HMC-1 cell, with a calculated dissociation constant of 1. 29 +/- 0.3 nM. Purified urokinase induced dose-dependent migration of primary mast cells and HMC-1 in a chemotaxis assay without inducing release of histamine. The mast cell agonist stem cell factor also induced migration of HMC-1 and caused up-regulation of expression of urokinase receptor mRNA. Together, our data show that human mast cells express functional receptors for urokinase. Expression of urokinase receptors on mast cells may have implications for mast cell-dependent microvascular processes associated with fibrinolysis, migration, or local tissue repair.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9065447     DOI: 10.1074/jbc.272.12.7824

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

1.  Circulating levels of urokinase-type plasminogen activator (uPA) and its soluble receptor (suPAR) in patients with atopic eczema/dermatitis syndrome.

Authors:  Alicja Kasperska-Zajac; Barbara Rogala
Journal:  Inflammation       Date:  2005-04       Impact factor: 4.092

Review 2.  The urokinase receptor (u-PAR)--a link between tumor cell dormancy and minimal residual disease in bone marrow?

Authors:  Heike Allgayer; Julio A Aguirre-Ghiso
Journal:  APMIS       Date:  2008 Jul-Aug       Impact factor: 3.205

3.  Similarities in features of autism and asthma and a possible link to acetaminophen use.

Authors:  Kevin G Becker; Stephen T Schultz
Journal:  Med Hypotheses       Date:  2009-09-11       Impact factor: 1.538

4.  Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia.

Authors:  Sabine Cerny-Reiterer; Anja Rabenhorst; Gabriele Stefanzl; Susanne Herndlhofer; Gregor Hoermann; Leonhard Müllauer; Sigrid Baumgartner; Christine Beham-Schmid; Wolfgang R Sperr; Christine Mannhalter; Heinz Sill; Werner Linkesch; Michel Arock; Karin Hartmann; Peter Valent
Journal:  Oncotarget       Date:  2015-02-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.